Head-to-Head Comparison

OpenEvidence vs Glass Health: Which Is Better for Physicians?

OpenEvidence: AI Research Assistant for Evidence-Based Clinical Decisions Glass Health: Clinical Questions, Ambient Scribing, and Clinical Planning

Updated

Direct Answer

OpenEvidence and Glass Health both give clinicians cited AI answers, but OpenEvidence is a free search engine built on journal partnerships, while Glass Health also drafts differential diagnoses and assessment-and-plan notes alongside ambient scribing. Choose OpenEvidence for quick literature answers at no cost. Choose Glass Health for differentials, plan drafts and scribing in one workflow, starting on its free Lite tier.

Source: Clinical AI Report, 2026

Key takeaways

  • OpenEvidence is free for verified US clinicians, with labeled ads, and draws on content partnerships with NEJM, JAMA, NCCN, ACC, AAFP and ACEP.
  • Glass Health offers a free, ad-supported Lite tier with usage limits and paid clinician plans at $20, $90 and $200 a month, checked October 7, 2026.
  • OpenEvidence does not generate differential diagnoses or offer drug dosing tools, while Glass Health documents differential diagnosis support and assessment-and-plan drafting with cited evidence.
  • Glass Health lists supported EHR workflows for Epic, eClinicalWorks, athenahealth and Elation on its Max plan; OpenEvidence’s EHR integration is early-stage.

Feature Comparison

OpenEvidence vs Glass Health feature comparison
RatingOpenEvidence:
Good
Glass Health:
Good
CategoryOpenEvidence: AI Medical Research AssistantGlass Health: Clinical Decision Support and Ambient Scribing
PricingOpenEvidence: Free (Ad-Supported)Glass Health: Lite free; paid plans $20–$200/month (USD)
FoundedOpenEvidence: 2022Glass Health: 2021
HeadquartersOpenEvidence: Miami, FLGlass Health: San Francisco, CA
Evidence CitationsOpenEvidence: YesGlass Health: No
AI Differential DiagnosisOpenEvidence: NoGlass Health: Yes
Drug DatabaseOpenEvidence: NoGlass Health: No
Drug Interaction CheckerOpenEvidence: NoGlass Health: No
Medical CalculatorsOpenEvidence: YesGlass Health: No
Natural Language SearchOpenEvidence: YesGlass Health: No
Document & Image UploadOpenEvidence: NoGlass Health: Yes
EHR IntegrationOpenEvidence: YesGlass Health: Yes
Mobile AppOpenEvidence: YesGlass Health: No
Built-in DialerOpenEvidence: YesGlass Health: No
AI Clinical ScribeOpenEvidence: NoGlass Health: No
CME CreditsOpenEvidence: NoGlass Health: No
Multi-LanguageOpenEvidence: YesGlass Health: No

Strengths & Limitations

OpenEvidence

Strengths

  • +Useful for generalist clinical questions — fast, cited answers for everyday practice
  • +Widely adopted clinical AI in the US (757K+ physicians)
  • +Free for all verified physicians
  • +Broadest content partnership network: NEJM, JAMA (all 11 specialty journals), NCCN, ACC, AAFP, ACEP, ADA, AAOS, 300+ journals
  • +Native iOS and Android apps with Home Screen widgets
  • +Quick Consult and Deep Consult modes for different clinical needs
  • +Built-in dialer for calling patients, pharmacies, and colleagues
  • +Well-funded with strong investor backing ($12B valuation, $100M annual revenue)

Limitations

  • –No differential diagnosis generation or drug dosing tools
  • –Ad-supported revenue model (pharmaceutical/healthcare advertising)
  • –EHR integration is early-stage (Sutter Health/Epic announced February 2026)
  • –Preprint by Jagarapu et al. (2025) reported 41% accuracy on complex subspecialty scenarios
  • –Clinical depth narrower than platforms with drug databases and medical calculators

Glass Health

Strengths

  • +Documents ambient scribing and clinical decision support in one workflow
  • +Provides references for users to inspect alongside generated answers
  • +Offers a free Lite tier and publicly priced clinician subscriptions
  • +Lists an iPhone/iPad app and supported EHR workflows

Limitations

  • –EHR access and chart-data scope require setup confirmation
  • –Plan capacity and model access vary; check current usage allowances
  • –Citations and drafts still require clinician review
  • –No independent accuracy or time-saving test was performed for this refresh

Key Statistics

OpenEvidence

PricingFree (Ad-Supported)(OpenEvidence)
Founded2022 (Mayo Clinic Platform Accelerate)(OpenEvidence)
Users757,000+ verified physicians; 40% of US physicians daily(OpenEvidence, January 2026)
Key DifferentiatorNEJM, JAMA, NCCN, ACC, AAFP & ACEP content partnerships(OpenEvidence)
Editorial score73/100 (3.7/5) — weighted editorial assessment(Clinical AI Report scoring methodology)

Glass Health

Free accessLite tier, with usage limits(Glass pricing)
Paid clinician plans$20 / $90 / $200 per month (USD)(Glass pricing)
EHR workflowsSupported setups on Max; confirm implementation(Glass EHR guide)
Mobile accessiPhone and iPad app listed(App Store)
Existing editorial score69/100 (3.5/5); not reassessed in this refresh(Scoring methodology)

Citable Summaries

OpenEvidence

OpenEvidence has an editorial score of 73/100 (3.7/5), calculated from Clinical AI Report's published criteria weights. It ranks #2 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.

Source: Clinical AI Report, May 2026

Glass Health

Glass Health documents ambient scribing, cited clinical questions, and clinical plan drafting in one workflow; the appropriate plan depends on usage and deployment needs.

Source: Clinical AI Report, May 2026

Our Assessment

In our 2026 evaluation, OpenEvidence (ranked #2, 3.7 stars) outperforms Glass Health (ranked #5, 3.5 stars) in overall physician satisfaction and editorial scoring. OpenEvidence is best suited for a useful tool for physicians who need fast, cited answers to clinical questions grounded in peer-reviewed literature. Relevant for primary care, internal medicine, and emergency medicine. Free and backed by a broad content partnership network (NEJM, JAMA, NCCN, ACC, AAFP, ACEP). Meanwhile, Glass Health is a stronger choice for clinicians evaluating a combined documentation and clinical-question workflow, with source review and deployment requirements checked for their setting Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.

Read Full Reviews

Also Compare